96747 ⎘
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links Luteinising hormone-releasing hormone [LHRH]; Related peptides
METHOD FOR MANUFACTURING GANIRELIX
#2COMPOSITIONS AND METHODS FOR TREATING A MEDICAL CONDITION
#3LYTIC DOMAIN FUSION CONSTRUCTS, CHECKPOINT INHIBITORS, AND METHODS OF MAKING AND USING SAME
#4COMPOUND OR SALT THEREOF AND PREPARATION METHOD AND APPLICATION OF SAME
#5IMMUNORHELIN COMPOUNDS FOR INTRACELLULAR INFECTIONS
#6NOVEL COMPOUNDS (IMMUNORHELINS)
#7LHRH-platinum conjugates for treating reproductive cancers
#8PROCESS FOR THE PREPARATION OF DEGARELIX
#9Process for the manufacture of degarelix and its intermediates
#10COMPOUND OR SALT THEREOF AND PREPARATION METHOD AND APPLICATION OF SAME
#11PROCESS FOR THE MANUFACTURE OF DEGARELIX AND ITS INTERMEDIATES
#12Compounds (immunorhelins)
#13Immunorhelin compounds for intracellular infections
#14Process for the preparation of Cetrorelix acetate
#15LHRH-platinum conjugates for treating reproductive cancers
#16Therapeutic fusion proteins
#17Process for the manufacture of degarelix and its intermediates
#18METHODS AND COMPOSITIONS RELATED TO IMPROVING PROPERTIES OF PHARMACOLOGICAL AGENTS TARGETING NERVOUS SYSTEM
#19LHRH-platinum conjugates for treating reproductive cancers
#20Ganirelix precursor and method for preparing ganirelix acetate by using the same
#21PURIFICATION OF ORGANIC COMPOUNDS BY SURFACTANT MEDIATED PREPARATIVE HPLC
#22Target-Specific Double-Mutant Fusion Protein and Preparation Process Therefor
#23Process for the manufacture of degarelix and its intermediates
#24Curcumin conjugates for treating and preventing cancers
#25Methods and compositions related to improving properties of pharmacological agents targeting nervous system
#26Polyamine derivatives
#27Therapeutic fusion proteins
#28Recombinant pokeweed antiviral proteins, compositions and methods related thereto
#29Polyamine derivatives
#30Process for the manufacture of Degarelix and its intermediates
#31Process for the manufacture of Degarelix and its intermediates
#32Polyamine derivatives
#33Methods and compositions related to improving properties of pharmacological agents targeting nervous system
#34Novel Process For The Preparation Of Leuprolide And Its Pharmaceutically Acceptable Salts Thereof
#35Lytic peptides having anti-proliferative activity against prostate cancer cells
#36Phage-GnRH Constructs, Their Mimics, Antigenic Compositions, and Sequences for Immunocontraception of Animals and Other Applications
#37Protein for the immunocastration for mammals
#38Neuroprotective iron chelators and pharmaceutical compositions comprising them
#39LHRH-II PEPTIDE ANALOGS
#40Method for the manufacture of degarelix
#41Recombinant pokeweed antiviral proteins, compositions and methods related thereto
#42Linkers For Radiopharmaceutical Compounds
#43Curcumin conjugates for treating and preventing cancers
#44RNA VECTOR THERAPY METHOD
#45RNA VECTOR THERAPY
#46Artificial decapeptide for inducing vitellogenesis in fish
#47GnRH II Analogs and Uses Thereof in the Immune System
#48CONJUGATES OF DISORAZOLES AND THEIR DERIVATIVES WITH CELL-BINDING MOLECULES, NOVEL DISORAZOLE DERIVATIVES, PROCESSES OF MANUFACTURING AND USES THEREOF
#49Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof
#50Solid Phase Peptide for the Production of Goserelin
#51Polyamine derivatives
#52Methods of treating reproductive cancer
#53Ligand/lytic peptide methods of use
#54Methods and compositions related to improving properties of pharmacological agents targeting nervous system
#55Method of preparing peptide
#56Retro-inverso gonadotropin-releasing hormone peptide and vaccine composition
#57TRUNCATED LHRH FORMULATIONS
#58Gonadotropin releasing hormone antagonists
#59Sustained-release preparation
#60USE OF CELL IMPLANTS IN BLADDER AND GUT OF NON-HUMAN ANIMALS FOR THE PRODUCTION OF PEPTIDES
#61Carrier conjugates of gnrh-peptides
#62Solution-phase synthesis of leuprolide and its intermediates
#63Intermediates for LHRH antagonist synthesis, process for the production, and process for LHRH antagonist production
#64Novel Gonadotropin-Releasing Hormone, Precursor Peptides Thereof and Genes Encoding the Same
#65Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof
#66Application of initial doses of LHRH analogues and maintenance doses of LHRH antagonists for the treatment of hormone-dependent cancers and corresponding pharmaceutical kits
#67Peptides Useful for Treating Gnrh Associated Diseases
#68Chimeric peptide immunogens
#69Peptide vectors
#70Methods of treatment using novel LHRH antagonists having improved solubility properties
#71Methods for the production of peptide derivatives
#72Linkers for radiopharmaceutical compounds
#73Neuroprotective iron chelators and pharmaceutical compositions comprising them
#74Novel GnRH analogues with antitumour effects and pharmaceutical compositions thereof
#75Agonists and antagonists of gonadotropin-releasing hormone-2, and use thereof
#76Lamprey GnRH-III polypeptides and methods of making thereof
#77Process for preparing LH-RH derivatives
#78Transient and/or permanent modification of sexual behavior and/or fertility using recombinant chimeric GnRH
#79Two gonadotropin releasing hormones and a method to isolate the same
#80Method of preparing peptide
#81Methods and pharmaceutical compositions for GnRH-I and GnRH-II modulation of T-cell activity, adhesion, migration and extravasation
#82Gonadotropin-releasing hormone, precursor peptides thereof and genes encoding the same
#83Intermediates for lhrh antagonist synthesis, process for their production, and process for lhrh antagonist production
#84Chimeric peptide immunogens
#85Chimeric peptide immunogens
#86Fusion proteins comprising carriers that can induce a dual immune response
#87Non-mammalian GnRH analogs and uses thereof in regulation of fertility and pregnancy
#88Non-mammalian GnRH analogs and uses thereof in the immune system
#89Oral absorbed drugs